Classical maple syrup urine disease and brain development: Principles of management and formula design
- 17 December 2009
- journal article
- clinical trial
- Published by Elsevier BV in Molecular Genetics and Metabolism
- Vol. 99 (4), 333-345
- https://doi.org/10.1016/j.ymgme.2009.12.007
Abstract
No abstract availableThis publication has 77 references indexed in Scilit:
- Role of docosahexaenoic acid in maternal and child mental healthThe American Journal of Clinical Nutrition, 2009
- Dual mechanism of brain injury and novel treatment strategy in maple syrup urine diseaseBrain, 2008
- Social outcome in adults with maple syrup urine disease (MSUD)Journal of Inherited Metabolic Disease, 2007
- Omega-3 fatty acids as treatments for mental illness: which disorder and which fatty acid?Lipids in Health and Disease, 2007
- The case for regulating indispensable amino acid metabolism: the branched-chain α-keto acid dehydrogenase kinase-knockout mouseBiochemical Journal, 2006
- Impaired growth and neurological abnormalities in branched-chain α-keto acid dehydrogenase kinase-deficient miceBiochemical Journal, 2006
- Dendritic development in neocortex of infants with early postnatal life undernutritionPediatric Neurology, 1993
- Abnormal dendritic development in maple syrup urine diseasePediatric Neurology, 1992
- Cerebral edema causing death in children with maple syrup urine diseaseThe Journal of Pediatrics, 1991
- Serum selenium levels in individuals on PKU dietsJournal of Inherited Metabolic Disease, 1991